Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.76 USD | +2.57% | +3.79% | -33.96% |
Apr. 23 | Oppenheimer Upgrades AtriCure to Outperform, Price Target at $32 | MT |
Apr. 18 | AtriCure, Inc. Announces Launch of the CryoSPHERE®?+ Probe for Post-Operative Pain Management | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.96% | 1.12B | |
-2.09% | 187B | |
-2.37% | 106B | |
-4.11% | 66.9B | |
+1.89% | 49.45B | |
+16.82% | 48B | |
+4.06% | 40.84B | |
+2.77% | 26.48B | |
+1.61% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- ATRC Stock
- News AtriCure, Inc.
- AtriCure Reports Higher Preliminary Q4, 2023 Revenue; Issues 2024 Revenue Guidance; Shares Rise